{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:46:34Z","timestamp":1778453194204,"version":"3.51.4"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,2,1]]},"DOI":"10.2169\/internalmedicine.5340-20","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T22:10:43Z","timestamp":1598652643000},"page":"385-389","source":"Crossref","is-referenced-by-count":8,"title":["Intermittent Purpura Development Associated with Leukocytoclastic Vasculitis Induced by Infliximab for Crohn's Disease"],"prefix":"10.2169","volume":"60","author":[{"given":"Kenichi","family":"Kishimoto","sequence":"first","affiliation":[{"name":"Department of Internal Medicine II, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousaku","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Fukunaga","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kotani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Sonoyama","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Mishima","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Oshima","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihisa","family":"Ishimura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyoshi","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riruke","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Ishihara","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Ramos-Casals M, Brito-Zer\u00f3n P, Mu\u00f1oz S, et al. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 86: 242-251, 2007."},{"key":"2","unstructured":"2. Fr\u00e9ling E, Baumann C, Cuny JF, et al. Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience. Am J Gastroenterol 110: 1186-1196, 2015."},{"key":"3","unstructured":"3. Cleynen I, Van Moerkercke W, Billiet T, et al. Characteristics of skin lesions associated with anti-tumor necrosis factor therapy in patients with inflammatory bowel disease: a cohort study. Ann Intern Med 164: 11-22, 2016."},{"key":"4","unstructured":"4. Moustou AE, Matekovits A, Dessinioti C, Antoniou C, Sfikakis PP, Stratigos AJ. Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review. J Am Acad Dermatol 61: 486-504, 2009."},{"key":"5","unstructured":"5. Moran GW, Lim AW, Bailey JL, et al. Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease. Aliment Pharmacol Ther 38: 1002-1024, 2013."},{"key":"6","unstructured":"6. Mocci G, Marzo M, Papa A, Armuzzi A, Guidi L. Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel disease. J Crohns Colitis 7: 769-779, 2013."},{"key":"7","unstructured":"7. Torres J, Bonovas S, Doherty G, et al. ECCO guidelines on therapeutics in Crohn's disease: medical treatment. J Crohns Colitis 14: 4-22, 2020."},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Colombel JF, Sandborn WJ, Rutgeerts P, et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology 132: 52-65, 2007.","DOI":"10.1053\/j.gastro.2006.11.041"},{"key":"9","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jbspin.2006.02.010","volume":"73","author":"B Saint Marcoux","year":"2006","unstructured":"9. Saint Marcoux B, De Bandt M. Vasculitides induced by TNF\u03b1 antagonists: a study in 39 patients in France. Joint Bone Spine 73: 710-713, 2006.","journal-title":"Joint Bone Spine","ISSN":"https:\/\/id.crossref.org\/issn\/1297-319X","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Song Y, Shi YH, He C, et al. Severe Henoch-Sch\u00f6nlein purpura with infliximab for ulcerative colitis. World J Gastroenterol 21: 6082-6087, 2015.","DOI":"10.3748\/wjg.v21.i19.6082"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Rahman FZ, Takhar GK, Roy O, Shepherd A, Bloom SL, McCartney SA. Henoch-Sch\u00f6nlein purpura complicating adalimumab therapy for Crohn's disease. World J Gastrointest Pharmacol Ther 1: 119-122, 2010.","DOI":"10.4292\/wjgpt.v1.i5.119"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Marques I, Lagos A, Reis J, Pinto A, Neves B. Reversible Henoch-Sch\u00f6nlein purpura complicating adalimumab therapy. J Crohns Colitis 6: 796-799, 2012.","DOI":"10.1016\/j.crohns.2012.02.019"},{"key":"13","unstructured":"13. Michel BA, Hunder GG, Bloch DA, Calabrese LH. Hypersensitivity vasculitis and Henoch-Sch\u00f6nlein purpura: a comparison between the 2 disorders. J Rheumatol 19: 721-728, 1992."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Mills JA, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Sch\u00f6nlein purpura. Arthritis Rheum 33: 1114-1121, 1990.","DOI":"10.1002\/art.1780330809"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Rolle AS, Zimmermann B, Poon SH. Etanercept-induced Henoch-Sch\u00f6nlein purpura in a patient with ankylosing spondylitis. J Clin Rheumatol 19: 90-93, 2013.","DOI":"10.1097\/RHU.0b013e3182863027"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/3\/60_5340-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T05:46:07Z","timestamp":1612590367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/3\/60_5340-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5340-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}